3SOF

Cuisine Solutions Inc. (FZN)


simply it is the first stock i have seen that has been going up with great consistancy over a period. of several years. Ihave only recently come across this site and hope to become better at investing and learning of the forum. I would like to be in this contest for the fun and hopefull the winnings tks all seaity

1)   SUF(SULPHCO INC)

2)   The reason for my pick is simple, when the chart is on fire, it takes a alot of effort to cool it off.  
The chart looks bullish with strong trending up and with steady increasing volumes to support it.  Another strong point is that while overall market head down south in da big way this past week, SUF continues to show strength with big rallies.  Due to the fact that it has something to do with oil & gas. It is a development stage company, engages in the development and commercialization of technology for upgrading and desulfurizing of crude oil and petroleum products. Its Sonocracking process is based upon the use of ultrasonics that include the application of energy and frequency sound waves to effect beneficial changes, such as reduction in the weight percentage of sulfur, as well as a reduction in the parts per million of nitrogen in the chemical composition of crude oil. The company's target customers include crude oil producers and refiners. SulphCo has a collaboration agreement with ChevronTexaco Energy Technology Co. to develop and commercialize Sonocracking ultrasound technology; and a joint venture with Trans Gulf Petroleum Co. to implement SulphCo's Sonocracking desulfurization technology within and outside the UAE.

3)   SUF 3 month chart & its incredible 3 year chart, BREAKING OUT!>

Stock pick: RITA (Rita Medical Systems)

The reasons for my pick are totally technical, not fundamental.  I'm basically a short-term technical trader and don't pay a lot of attention to fundamentals.  The stock just broke through the double-top resistance on increasing volume.  I just noticed this stock today when I was looking for a stock breaking out and possibly starting a new uptrend.  I use trend-following as my main technique.  It has been the most successful for me over the 9 months I've been trading.  The MACD is bullish, and the ADX looks like it's on its way up, which would indicate that a trend is in place.  I consider it a trend, even though the ADX is only 20, because it's been bouncing between the 5EMA and the upper bollinger band, even poking through it, which indicates strength.  I'm probably going to buy some of this on Monday.

Leaira

Sticking with my pick from the last 2 contests, and inspite of a 1:4 reverse split I am going with.  Last month it yielded 12^ gain good enough for 10th place... one of these days this thing is going to move.. this will be the last time I enter it.

Avanir Pharm... AVN-R (new symbol)  www.avanir.com
New CEO Eric Brandt of AGN fame
possible nasdaq listing
earnings Feb 9
possible fda approval
big Orbimed holding

good luck to everyone

My pick is Arena Resources, Inc. Ticker ARD. Its listed on AMEX.

1. Fundamentally. The Next UPL.
This one seems to be next UPL [I always doubted its EPS near 50s and was always wrong to underestimate the growth story. Heck I am not repeating the mistake this time]. ARD is one of the fastest growing companies according to IBD. Though it has already booked gains of nearly 300% but I think there is more to come.
Revenue (ttm):                   19.45M
Revenue Per Share (ttm):   1.914
Qtrly Revenue Growth (yoy):   215.40%
EBITDA (ttm):                   13.92M
Qtrly Earnings Growth (yoy):   316.90%
Profit Margin (ttm):                   38.03%
Operating Margin (ttm):   61.24%
Total Debt (mrq):                   400.00K
Shares Outstanding:                   13.06M
% Held by Insiders:                   17.07%
Market Cap (intraday):                    471.54M
Forward P/E (fye 31-Dec-06):   20.40
Mean Recommendation:               1.0

2. Technically: FAST and FURIOUS.
This is one of the best technical play beating both 50 and 200 days averages and trading above its 52 week high. Trend is a friend in play here.
52-Week Change:                   282.01%
S&P500 52-Week Change:   8.02%
52-Week High (20-Jan-06):   36.10
52-Week Low (21-Jan-05):   8.98
50-Day Moving Average:   29.12
200-Day Moving Average:   21.45

3. Speculatively. BLACK GOLD.
There is a mismatch in energy demand and supply. Fast growing economies and delicate international conditions are just the right reasons to bet that crude is heading North or even if it flirts with 70s, its going to put lot of value in the whole Energy sector.

Below is the stock chart showing strong, steady ascend to clear blue skies.

just wrote a whole thing and lost it in computer land>
my pick is INSM. yet another biopharm . currently at 2.70 can it rise 48% to get to 4bucks within a month?
i certainly think so.
what have they done lately ? well the short term chart tells you that.
i am not much on fundamentals but can they pay their bills?
Total Current Assets 21,093m
Total Current Liabilities 4,019  
so they can pay their bills .
the chart looks promising short and long term. although i was dissapointed with the last couple of days action (maybe next contest could be a shorting comp)
here is a long and short term chart,
good luck to all
maxi









good luck to all

1)   COGO - COMTECH GROUP Inc.

2)   Comtech Group Inc is a leading design solution provider that serves the wireless, telecom equipment and home entertainment industries in China. The Company reported back in November 31% year to date revenue growth. Cash and equivalents increased from $5.0 million in December 2004 to $33.1 in November 2005. Its subsidiary, Comtech Wireless Ltd, also singed a contract with China Telecom. On the same month JMP Securities analyst Krishna Shankar upgraded the stock to "strong buy". In December 2005 Maxim Group initiated Comtech with a "buy" rating.  Most recently Comtech said it has acquired 51% stake in Huameng Engineering Service Ltd. for $2.5 million cash. It also added on its press release the following:

"Comtech expects Huameng to generate meaningful revenue in 2006, and more importantly through Huameng, Comtech will be receiving recurring service revenue with a gross margin over 40 percent, which is significantly higher than the company's current blended margin. The recurring service revenue should improve Comtech's overall margin, visibility and further diversify revenue streams."

3)   On these news the stock broke through $6.66 resistance point on high volume. The short and long term indicators are bullish. The next resistance point is $8.14. With the healthy pull back this past week COGO should now move upwards. The upcoming earnings report should provide a solid idea of where the stock is heading though.

TVIA - TVIA Inc

TVIA is a small cap semiconductor player in a hot end market - Designs, develops and markets display processors for the interactive-television market and HD and SD LCD TVs. They IPO'd in the tech meltdown and their stock has never recovered to IPO levels since. Seem to have some strong management in place with growth and profit goals key to their approach. After double bottom about 9 months back volume and price has increased nicely. Recent trading on strong volume has seen an attempt at new 52 week high (following big pullback during Q4), although as yet only a spike test was achieved. Weekly MACD signals a buy and my thought is it will either blast through the 52 week high zone or create a double top and falter. This is also an earnings play as results are due in early Feb and thought is TVIA may be making traction against bigger competitors.
I have TVIA as a current trade in my own portfolio as my buy was triggered as it created a new 52 week high last week.

-- it is indicated as i have less than 10 posts, but if you click on my name you will see i have about 70

My pick is: GOOG

Somebody must have the dullest stock out there! -

The co doesnt need much introduction, i guess

Friday there was a huge sell off, on news and bcz there was a sell-off. GOOG will not stay long under 400 i think - when the indicators turn, shorts will cover - so perfect timing.
Google is everywhere, now also in this contest!

VICL - Vical Inc.

Vical has been somewhat of a disappointment the past year but hopefully 2006 will be the year I was looking for last year. They engage in the research and development of biopharmaceutical products for the prevention and treatment of serious or life-threatening diseases. The company focuses on the development of biopharmaceutical product candidates based on its patented deoxyribonucleic acid (DNA) delivery technologies - which could turn this company into a cash cow!.

It also develops various DNA-based vaccines and therapeutics for the prevention or treatment of infectious diseases, cancer, and cardiovascular diseases. Vical primarily develops its cancer immunotherapeutics, Allovectin-7 and IL-2/Electroporation, as well as a plasmid DNA vaccine for cytomegalovirus. Allovectin-7, which completed its Phase II clinical trials, is a plasmid/lipid complex containing the DNA sequences encoding HLA-B7 and ß2 microglobulin, which together form a Class I Major Histocompatibility Complex antigen. Allovectin-7 is being developed as a treatment for metastatic melanoma, a form of skin cancer. IL-2/Electroporation program that is in Phase 1 clinical testing is a gene-based, electroporation enhanced delivery of interleukin-2, or IL-2, a potent immunotherapeutic agent, as a treatment for solid tumors, with an initial indication in metastatic melanoma.

Vical also develops an anthrax vaccine, which is in Phase 1 clinical testing. The company was incorporated in 1987 and is based in San Diego, California.

I really shouldn't be doing this but I'm going to pick the same stock for the third consecutive contest.  Sorry!   

1)   Stock Pick
ASTM - Aastrom Biosciences Inc.

Aastrom Biosciences, Inc. (NasdaqSC: ASTM) is developing patient-specific products for the repair or regeneration of human tissues, utilizing the Company's proprietary adult stem cell technology.


2)   Reason behind this pick

ASTM is a great company with big potential in the near future.  Their technology uses a fascinating idea in that it uses a person's own stem cells (from bone marrow) to treat severe bone fractures, vascular diseases, jaw bone reconstruction as well as spine fusion.  It has many clinical trials actively going on in both US and in Europe.  Soon they will be opening a manufacturing site in Europe and hoping to rake in big bucks.   Good luck to everyone!

Recent deveopments:
Dr. Armstrong (CEO) recently notified that Aastrom that they should currently seek a new CEO.  However, he will remain chairman of the board of directors.  I really don't know what to make of this news.............to me, it either means that he is stepping down cause Aastrom's technology has been proven and that they are ready for the next stage in the company which is commercialization OR there is really something bad happening within the company that haven't been announced.  Anybody have a take on this??

Aastrom also recently announced the addition of a new director to the board of Directors.  Here is some news on the new addition:

Zerbe Joins:
Robert L. Zerbe, MD, joins the board
April 3rd, 2002

Synaptic Pharmaceutical Corp.

Synaptic Pharm Acquired:
Synaptic Pharmaceutical Completes Its Merger With A Subsidiary of H. Lundbeck A/S
PARAMUS, N.J., March 6


Zerbe Joins Maxim Pharm:
Maxim Pharmaceuticals Announces Robert L. Zerbe Nominated to Its Board of Directors
SAN DIEGO--(BUSINESS WIRE)--Jan. 14, 2003--Maxim Pharmaceuticals

Acquired:
EpiCept Corporation Completes Merger with Maxim Pharmaceuticals
EpiCept (UNITED STATES)
January 5, 2006 [can't get link, you can fin it]

Zerbe joins Corgentech:
AlgoRx and Corgentech Announce Addition of Ninth Board Member to Proposed Board of Directors for Combined Company
SECAUCUS, N.J. and SOUTH SAN FRANCISCO, Calif., Nov 15, 2005

Corgentech Upgraged:
Corgentech upgraded to "market perform"

Wednesday, December 21, 2005 7:51:46 AM ET
Piper Jaffray


Corgentech acquires AlgoRx prior to upgrade:


Lastly: Zerbe's own company recently merged with Hormos Medical Corporation in Finland


Aastrom's pps have not been moving up or down in either direction.  IMO, this company will make a move soon whether it's in the positive direction or the negative direction.  Hopefully not the latter.

VRSO - VERSO TECH INC (NasdaqSC)

I`ll  try again with VRSO, it was up 41% the other day on this news:

Verso Technologies Inc., a maker of telecommunications equipment,
on Thursday said it expects fourth-quarter revenue to grow as much
as 25 percent due to a sales shift toward higher-margin products.

The company estimates revenue will range from $9.4 million to
$9.5 million, compared with year-ago revenue of $7.6 million.
Chief Executive Monty Bannerman said he expects the company to post
"solid revenue growth in 2006 and show operating margin improvement
as Verso continues to focus its sales effort on higher gross margin
applications, coupled with continued tight management of operating
expenses."

Verso plans to report results for the fourth quarter on Feb. 22.

Then perhaps  it`s my turn to get an interview with 3STOCKSonFire ?

My pick for this round is a small cap called AERTA.
AERTA manufactures and markets composite building materials that can be used as an alternative to traditional wood products for certain applications in the construction industry.

Fundamental reason:
The company has been doing very well recently. 2004 their net income was 1.5 millions but so far for 2005 their net income is about 3.4 millions (4 quarter excluded). Recently they announced that  unaudited gross sales for the quarter ended December 31, 2005 were $24 million, up 55% over gross sales of $15.5 million for the quarter ended December 31, 2004.
There was some insider buying late November.

Technical reason:
Recently the stock advanced more than 40% (in less than two weeks) but last Friday they had a very welcomed pullback (with RSI over 85). So I expect it to start climbing soon (maybe this is not a fast enough climber for such a short time frame...).
If it breaks 2.50 I think we could be in for a ride.

MYGN - Myriad Genetics

Myriad Genetics is a leading biopharmaceutical company focused on the development of novel healthcare products. The Company's lead drug candidate, FLURIZAN™, is currently accepting enrollment for a Phase 3 clinical trial in Alzheimer's disease. This compound is also being studied in a Phase 2b clinical trial for prostate cancer therapy. Myriad has a full pipeline of preclinical drug candidates in development and recently started Phase I human clinical trials for two additional cancer drugs, MPC-6827 and MPC-2130. The Company markets hereditary cancer predictive medicine tests to determine the risk of breast cancer, ovarian cancer, colon cancer, endometrial cancer and melanoma skin cancer in individuals with a family history of cancer.

This is an interesting biopharm play with lots of research into cancer and alzheimer's disease.  As positive news continues to come out regarding the current clinical trials, expect nice increases in share price.  I won't bet on winning this contest, but this is definately one to keep your eye on.

I almost re-entered my last contest choice SMSI but decided to take on:
My pick: MEMY
A past 3stocksonfire pick. This company developes drugs for nervous system disorders. Has 5 drugs in clinical & preclinical stages. Has agreements with F. Hoffman LaRoche, Amgen, and Stanley Medical. Big Insider purchases in Sept. Recent Institutional buy interest +3.8 mil shares. But it's the current TA that has me interested. MACD- Bullish; Strong uptrend: Relative Strength-Bullish; Up/Down volume shows stock under accumulation; 50 day MA-Bullish. Friday's close highest since Oct 5th 2005. Broke 2.50 resistence. Closed above 200 day SMA. Close above 3.25 could be hugh. Earnings should be out during contest period but I'm looking for more trial results. If I get them I might finish this race.